Amgen Criticizes Draft Report Before Publication

Amgen is criticizing ICER’s assessments in a recent draft report that hasn’t even been published yet. Find out more here. (Source: Jaimy Lee, MM&M, 4/5/16)

You might also be interested in:

Department of Veterans Affairs Paid About Half as Much as… 01/15/2021
Panalgo's IHD Platform to Be Used by the EU Medicines Agency… 01/06/2021
2 of 3 Americans Reveal Healthcare Insecurity and Problems… 08/08/2020
State Level Action in Response to ICER’s Unsupported Price… 01/18/2021
How Can New Software Bolster HTA? 05/04/2020
ISPOR Offers Short Courses on Medical Devices, Payment Models 06/26/2020
Big Pharma's Stealthy Efforts to Undermine ICER 09/11/2020